Veterinärmedizinische Universität Wien Forschungsinformationssystem VetDoc

Grafischer Link zur Startseite der Vetmeduni Vienna

Gewählte Publikation:

Publikationstyp: Zeitschriftenaufsatz
Dokumenttyp: Position Paper

Jahr: 2020

AutorInnen: Jensen-Jarolim, E; Bachmann, MF; Bonini, S; Jacobsen, L; Jutel, M; Klimek, L; Mahler, V; Mösges, R; Moingeon, P; O Hehir, RE; Palomares, O; Pfaar, O; Renz, H; Rhyner, C; Roth-Walter, F; Rudenko, M; Savolainen, J; Schmidt-Weber, CB; Traidl-Hoffmann, C; Kündig, T

Titel: State-of-the-art in marketed adjuvants and formulations in Allergen Immunotherapy: a position paper of the European Academy of Allergy and Clinical Immunology (EAACI).

Quelle: Allergy. 2020; 75(4):746-760



Autor/innen der Vetmeduni Vienna:

Jensen-Jarolim Erika
Roth-Walter Franziska

Beteiligte Vetmed-Organisationseinheiten
Messerli Forschungsinstitut, Abteilung für Komparative Medizin


Abstract:
Since the introduction of allergen immunotherapy (AIT) over 100 years ago, focus has been on standardization of allergen extracts, with reliable molecular composition of allergens receiving the highest attention. While adjuvants play a major role in European AIT, they have been less well studied. In this Position Paper, we summarize current unmet needs of adjuvants in AIT citing current evidence. Four adjuvants are used in products marketed in Europe: aluminium hydroxide (Al(OH)


© Veterinärmedizinische Universität Wien Hilfe und Downloads